Table S2. Univariate and multivariate analysis for prediction of TIM-3 expression on TILs in NSCLC patients.
Variables | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | P | Odds ratio | 95% CI | P | ||
Age (<70 y vs. ≥70 y) | 2.845 | 0.809–9.998 | 0.103 | ||||
Sex (female vs. male) | 1.26 | 0.257–6.169 | 0.776 | ||||
Smoking status (nonsmoker vs. smoker) | 0.407 | 0.043–3.825 | 0.431 | ||||
Pathological type (non-adenocarcinoma vs. adenocarcinoma) | 0.922 | 0.232–3.669 | 0.909 | ||||
Stage (I–II vs. III–IV) | 1.768 | 0.510–6.132 | 0.369 | ||||
PD-L1 on tumor cells (negative vs. positive) | 1.275 | 0.255–6.364 | 0.767 | ||||
PD-1 on TILs (negative vs. positive) | 1.644 | 0.477–5.669 | 0.431 | ||||
PD-L1 on TILs (negative vs. positive) | 2.291 | 0.662–7.929 | 0.191 |
NSCLC, non-small cell lung cancer; TIL, tumor infiltrating lymphocyte.